I. Weisberg

发表

Characterization of mutations in severe methylenetetrahydrofolate reductase deficiency reveals an FAD‐responsive mutation

R. Rozen, S. Sibani, D. Leclerc, 2003, Human mutation.

Cardiovascular diseases and the liver.

I. Weisberg, I. Jacobson, 2011, Clinics in liver disease.

Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature

K. Jhaveri, F. Muggia, I. Weisberg, 2013, Breast Cancer Research and Treatment.

Viral hepatitis screening in transgender patients undergoing gender identity hormonal therapy

I. Weisberg, N. Mangla, R. Mamun, 2017, European journal of gastroenterology & hepatology.

The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis

P. Korrapati, I. Weisberg, N. Valentin, 2018, European journal of gastroenterology & hepatology.

Pregnancy Outcomes After Liver Transplantation: A Systematic Review and Meta-Analysis.

I. Weisberg, M. Hershman, N. Valentin, 2021, The American journal of gastroenterology.

Primer on Hepatitis C Virus Resistance to Direct-Acting Antiviral Treatment: A Practical Approach for the Treating Physician.

I. Weisberg, I. Jacobson, 2017, Clinics in liver disease.

Aspirin Resistance: Prospective evaluation of increased cardiovascular risk in aspirin nonresponsive patients

I. Weisberg, 2005 .

Telaprevir: hope on the horizon, getting closer.

I. Weisberg, I. Jacobson, 2009, Clinics in liver disease.

Portal vein thrombosis prevalence and mortality among alcoholic cirrhosis in a nationwide inpatient cohort

I. Weisberg, M. Hershman, Xiaoquan Huang, 2019, European journal of gastroenterology & hepatology.

Transvenous Liver Biopsy

I. Weisberg, Robert S. Brown, S. Sigal, 2010 .

Hepatitis B and end-stage liver disease.

I. Weisberg, Robert S. Brown, S. Sigal, 2007, Clinics in liver disease.

New treatments for hepatitis C: Life cycle lessons

I. Weisberg, I. Jacobson, S. Sigal, 2007 .

Discovery and Development of Telaprevir

B. Govinda Rao, Ann D. Kwong, A. Kwong, 2011 .

A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity.

R. Rozen, S. Sibani, I. Weisberg, 1998, Molecular genetics and metabolism.

Hemochromatosis: pathophysiology, evaluation, and management of hepatic iron overload with a focus on MRI

Sara C Lewis, I. Weisberg, Shmuel Golfeyz, 2018, Expert review of gastroenterology & hepatology.

Common variant in betaine‐homocysteine methyltransferase (BHMT) and risk for spina bifida

R. Rozen, N. Sabbaghian, I. Weisberg, 2003, American journal of medical genetics. Part A.

The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine.

J H Eckfeldt, Zhoutao Chen, R. Rozen, 2001, Atherosclerosis.

Worth a second look.

I. Weisberg, B. Alobeid, D. Diuguid, 2009, The American journal of medicine.

Investigations of a common genetic variant in betaine-homocysteine methyltransferase (BHMT) in coronary artery disease.

R. Rozen, K. Ballman, P. Berger, 2003, Atherosclerosis.

Clinicopathological and Imaging Features of Primary Biliary Cholangitis

I. Weisberg, A. Dinani, M. Xie, 2022, medRxiv.

A pangenotypic, single tablet regimen of sofosbuvir/velpatasvir for the treatment of chronic hepatitis C infection

I. Weisberg, I. Jacobson, 2017, Expert opinion on pharmacotherapy.

Efficacy and Safety of Endoscopic Ultrasound-Guided Liver Biopsies in Parenchymal Liver Diseases: A Systematic Review and Meta-Analysis

I. Weisberg, M. Hershman, Anup B. Shah, 2018, American Journal of Gastroenterology.

Colonic Mucosubmucosal Elongated Polyp in the Sigmoid Colon on Surveillance Colonoscopy

I. Weisberg, M. Hershman, G. Levi, 2019, ACG case reports journal.